Roche And Biogen Settle Patent Row Over Arthritis Biosimilar
Pharmaceutical company Hoffmann-La Roche Inc. has settled a patent lawsuit alleging that Biogen MA Inc.'s proposed similar version of Roche's rheumatoid arthritis drug Actemra infringed several patents, according to a joint stipulation...To view the full article, register now.
Already a subscriber? Click here to view full article